[go: up one dir, main page]

GB201816670D0 - Stem cells - Google Patents

Stem cells

Info

Publication number
GB201816670D0
GB201816670D0 GBGB1816670.2A GB201816670A GB201816670D0 GB 201816670 D0 GB201816670 D0 GB 201816670D0 GB 201816670 A GB201816670 A GB 201816670A GB 201816670 D0 GB201816670 D0 GB 201816670D0
Authority
GB
United Kingdom
Prior art keywords
stem cells
stem
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1816670.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reneuron Ltd
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Priority to GBGB1816670.2A priority Critical patent/GB201816670D0/en
Publication of GB201816670D0 publication Critical patent/GB201816670D0/en
Priority to JP2021545340A priority patent/JP2022513355A/en
Priority to US17/284,428 priority patent/US20210371828A1/en
Priority to AU2019356209A priority patent/AU2019356209A1/en
Priority to PCT/GB2019/052908 priority patent/WO2020074925A2/en
Priority to SG11202103096PA priority patent/SG11202103096PA/en
Priority to EP19786653.6A priority patent/EP3864141A2/en
Priority to CA3115892A priority patent/CA3115892A1/en
Priority to KR1020217013800A priority patent/KR20210102195A/en
Priority to CN201980067680.XA priority patent/CN113015794A/en
Priority to IL282159A priority patent/IL282159A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GBGB1816670.2A 2018-10-12 2018-10-12 Stem cells Ceased GB201816670D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1816670.2A GB201816670D0 (en) 2018-10-12 2018-10-12 Stem cells
CN201980067680.XA CN113015794A (en) 2018-10-12 2019-10-11 Induced pluripotent cells comprising controllable transgenes for conditional immortalization
PCT/GB2019/052908 WO2020074925A2 (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
US17/284,428 US20210371828A1 (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalization
AU2019356209A AU2019356209A1 (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
JP2021545340A JP2022513355A (en) 2018-10-12 2019-10-11 Induced pluripotent cells containing controllable transgenes for conditional immortality
SG11202103096PA SG11202103096PA (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
EP19786653.6A EP3864141A2 (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
CA3115892A CA3115892A1 (en) 2018-10-12 2019-10-11 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation
KR1020217013800A KR20210102195A (en) 2018-10-12 2019-10-11 Induced Pluripotent Cells Containing a Controllable Transgene for Conditional Immortalization
IL282159A IL282159A (en) 2018-10-12 2021-04-08 Induced pluripotent cell comprising a controllable transgene for conditional immortalisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1816670.2A GB201816670D0 (en) 2018-10-12 2018-10-12 Stem cells

Publications (1)

Publication Number Publication Date
GB201816670D0 true GB201816670D0 (en) 2018-11-28

Family

ID=64394817

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1816670.2A Ceased GB201816670D0 (en) 2018-10-12 2018-10-12 Stem cells

Country Status (1)

Country Link
GB (1) GB201816670D0 (en)

Similar Documents

Publication Publication Date Title
IL276600A (en) Methods for manufacturing t cells
GB201813178D0 (en) Cell
IL273915A (en) Cell
GB201819540D0 (en) T cell modification
GB201712733D0 (en) Methods & cells
GB201714718D0 (en) Cell
GB201701509D0 (en) Pluripotenet stem cells
GB201803079D0 (en) Cell
GB201707779D0 (en) Cell
GB201720949D0 (en) Cell
GB201707783D0 (en) Cell
ZA202003594B (en) Robot cell
GB201718697D0 (en) Cell
GB201904971D0 (en) Cell
GB201720077D0 (en) Leukaemic stem cell
GB201816399D0 (en) Cell
GB201805287D0 (en) Haematoietic stem cell treatment
GB201807693D0 (en) Cell
GB201915526D0 (en) Modified cell
GB201906202D0 (en) Cell
GB2574854B (en) Cell selection procedures
GB201805918D0 (en) Cell
SG11202104087QA (en) Stem cell therapy
GB201816934D0 (en) Stem cells
GB201816670D0 (en) Stem cells

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)